PharmaCyte Biotech, Inc. (PMCB): auditor change — PharmaCyte Biotech engages Marcum LLP as new independent auditor after Armanino resignation

PharmaCyte Biotech, Inc.

Armanino resigned as independent auditor on August 1, 2023, citing exit from public company audit practice.
Marcum LLP was engaged as new independent registered public accounting firm on November 5, 2023.
No disagreements or reportable events occurred with Armanino during the past two fiscal years or subsequent period.
Company had not consulted Marcum on accounting principles or audit opinions prior to engagement.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

PharmaCyte Biotech, Inc. engaged Marcum LLP as its auditor.

Action: engagement
Auditor: Marcum LLP

Exact text from the filing

On November 5, 2023, the Company engaged Marcum LLP (“Marcum”) as its new independent registered public accounting firm

View on SEC.gov

Browse all auditor changes →

PharmaCyte Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-007830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.